iifl-logo-icon 1

Emmessar Biotech & Nutrition Ltd Board Meeting

41
(1.26%)
Jul 5, 2024|03:40:00 PM

Emmessar Biotech CORPORATE ACTIONS

07/07/2023calendar-icon
06/07/2024calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting29 May 202414 May 2024
EMMESSAR BIOTECH & NUTRITION LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 inter alia to consider and approve Pls refer attachment Pls refer attachment (As Per BSE Announcement Dated on 29.05.2024)
Board Meeting20 Mar 202427 Feb 2024
EMMESSAR BIOTECH & NUTRITION LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/03/2024 inter alia to consider and approve inducting / appointing an Independent Director on the Board of Directors Pursuant to Reg 30, LODR, Reg 2015, Mr. Dinesh Kumar Deora is appointed as Additional Independent Director w.e.f. 20.03.2024 (As Per BSE Announcement dated on 20.03.2024)
Board Meeting3 Feb 202423 Jan 2024
EMMESSAR BIOTECH & NUTRITION LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2024 inter alia to consider and approve Pursuant to Regulation 29 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of Board of Directors of the Company will be held on Saturday February 03 2024 at 12 Noon inter alia to consider and approve the Unaudited Financial Results of the Company for the Third quarter ended December 31 2023. The Board of Directors at their meeting held today approved and took on record the Un-Audited Financial Results for the quarter ended December 31, 2023. The results are filed along with the Limited Review. (As per BSE Announcement Dated on 03/02/2024) Revised outcome (As Per BSE Announcement dated on 21.02.2024)
Board Meeting9 Dec 202327 Nov 2023
EMMESSAR BIOTECH & NUTRITION LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/12/2023 inter alia to consider and approve Pursuant to Reg. 29 & 33 of SEBI (LODR) Regulations 2015 a meeting of Board of Directors will be held on Saturday December 09 2023 at 12 Noon to consider & Approve the Un-Audited Financial Result for the Quarter Ended September 30 2023. Pursuant to the provisions of Reg 30 & 47 of SEBI(LODR) Regulations, 2015, the newspaper clippings regarding the intimation of Board Meeting to be held on Saturday, December 09, 2023 at 12 Noon, published in the Free Press Journal & Nav Shakti dt 28-11-2023 are attached. (As Per BSE Announcement Dated on 28/11/2023) The Board of Directors at their meeting today approved and took on record the Un-Audited Financial Results for the second quarter ended September 30, 2023 The Board of Directors at their meeting today approved and took on record the Un-Audited Financial Results for the second quarter ended September 30, 2023 The Board of Directors at their meeting today approved and took on record the Un-Audited Financial Results for the second quarter ended September 30, 2023 (As Per BSE Announcement Dated on 09.12.2023)
Board Meeting27 Oct 202327 Oct 2023
The Board of Directors held the additional Board Meeting to appoint an additional director and to fix the date of EGM for voting the resolution which was missed during the AGM. There may be delay in submitting UA Financial Results & Non Applicability Cert of Corp Governance for the quarter ending September 30, 2023. Due to the resolution of approving Statutory Auditors was missed during AGM. As intimated earlier, the company has called for EGM to get the resolution passed. Hence we request you to grant us an extension of time regarding submission of Un Audited Financial Results and the Non Applicability Certificate of the Corporate Governance (As Per BSE Announcement Dated on 01.11.2023) At the meeting of the Board of Directors on Friday, October 27, 2023, Mr. Veeraraghava Ranganathan, DIN No. 00269682) have been appointed as a Non-Executive, Independent Director, Additional, with immediate effect. The appointment is subject to the approval by shareholders of the Company. (As Per BSE Announcement Dated on 08/11/2023)
Board Meeting10 Aug 202311 Jul 2023
EMMESSAR BIOTECH & NUTRITION LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2023 inter alia to consider and approve Pursuant to Regulation 29 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of Board of Directors of the Company will be held on Thursday August 10 2023 at 12.00 pm inter alia to consider and approve the Unaudited Financial Results of the Company for the first Quarter ended June 30 2023. Further Trading Window for dealing in Securities of the Company shall remain closed from July 01 2023 till expiry of 48 hours after declaration of Un-Audited Financial Results as intimated vide our letter dated 28th June 2023. The Board of Directors at its meeting today: 1. Approved the Un Audited Standalone Financial Results 2. Took on record the Limited Review Report issued by the Statutory Auditors 3. Finalised the date of the Annual General Meeting i.e. 29.09.2023. 4. 5. General discussion about other matters as per the agenda of the meeting. 6. Elected Mr. Srinivasa Raghavan Mathurakavi Ayyangar as the Chairman of the Company. He is now the Chairman and the Managing Director of the Company. 7. The approved the appointment the new Statutory Auditors (As Per BSE Announcement dated on 10.08.2023) The Boards of Directors during the meeting have approved the appointment the new statutory Auditors, M/s V. Nagarajan & Co, Charted Accounted the retiring statutory auditor, to hold the office for the conclusion of the 36th Annual General Meeting of the company to be held in the year 2028, Subject approval by the members of the company at the ensuing AGM. (As Per BSE Announcement Dated on 14.08.2023)

Emmessar Biotech: Related News

No record found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.